Arca
Skip to content

0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD…

Recall D-0374-2019, part of FDA recall event 81895. See PharMEDium Services's company page.

PharMEDium Services, LLC. started this Class II drug recall on Jan 2, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated May 7, 2020.

  • Classification: Class II
  • Started: Jan 2, 2019
  • Status: Terminated

Why It Was Recalled

Class II

Subpotent

Record

Product
0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.
Quantity
7,711 syringes
Lots and codes
Service Code 2K2466 and 2K2470 183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.
Distribution
Product was distributed throughout the United States.
Recalling firm
PharMEDium Services, LLC., Cleveland, MS, United States
How the firm notified
Letter
FDA classified
Jan 14, 2019

PharMEDium Services, LLC.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.